FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136749710> ?p ?o ?g. }

• W2136749710 endingPage "2330" @default.
• W2136749710 startingPage "2328" @default.
• W2136749710 abstract "A reduction in L-arginine availability has been implicated in the impairment of endothelium-dependent nitric oxide (NO)-mediated vasodilation by ischemia-reperfusion (I/R). However, the mechanisms contributing to dysregulation of the L-arginine pool remain unknown. Because endothelial cells can metabolize L-arginine via two major enzymes, that is, NO synthase (NOS) and arginase, we hypothesized that up-regulation of arginase during I/R reduces L-arginine availability to NOS and thus impairs NO-mediated vasodilation. To test this hypothesis, a local I/R was produced in the porcine heart by occlusion of a small branch of left anterior descending artery for 30 min, followed by reperfusion for 90 min. Arterioles (60-110 microm) isolated from non-ischemic and ischemic regions of subepicardium were cannulated and pressurized without flow for in vitro study. Vessels from both regions developed similar levels of basal tone. Although the dilation of I/R vessels to endothelium-independent agonist sodium nitroprusside was not altered, the endothelium-dependent NO-mediated dilations to adenosine and serotonin were attenuated. I/R not only inhibited arteriolar production of NO but also increased arteriolar arginase activity. Arginase inhibitor alpha-difluoromethylornithine enhanced NO production/dilation in normal vessels and also restored the NO-mediated function in I/R vessels. Treating I/R vessels with L-arginine also restored vasodilations. Immunohistochemical data revealed that I/R up-regulated arginase but down-regulated NOS expression in the arteriolar endothelium. Pretreating the animals with protein synthesis inhibitor cycloheximide prevented I/R-induced arginase up-regulation and also preserved NO-mediated vascular function. These results suggest that one mechanism by which I/R inhibits NO-mediated arteriolar dilation is through increased arginase activity, which limits the availability of L-arginine to NOS for NO production. In addition, the inability of arginase blockade or L-arginine supplementation to completely restore vasodilatory function may be attributable to the down-regulation of endothelial NOS expression." @default.
• W2136749710 created "2016-06-24" @default.
• W2136749710 creator A5015343493 @default.
• W2136749710 creator A5046597133 @default.
• W2136749710 creator A5050151730 @default.
• W2136749710 creator A5052573063 @default.
• W2136749710 creator A5074715088 @default.
• W2136749710 creator A5076529079 @default.
• W2136749710 date "2003-10-16" @default.
• W2136749710 modified "2023-10-17" @default.
• W2136749710 title "Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase" @default.
• W2136749710 cites W128790824 @default.
• W2136749710 cites W133994298 @default.
• W2136749710 cites W1525322545 @default.
• W2136749710 cites W1571274258 @default.
• W2136749710 cites W1573726519 @default.
• W2136749710 cites W1846153624 @default.
• W2136749710 cites W1957985734 @default.
• W2136749710 cites W1965693998 @default.
• W2136749710 cites W1968491125 @default.
• W2136749710 cites W1974528590 @default.
• W2136749710 cites W1978891369 @default.
• W2136749710 cites W1979119013 @default.
• W2136749710 cites W1982087424 @default.
• W2136749710 cites W1982363639 @default.
• W2136749710 cites W1983893679 @default.
• W2136749710 cites W1992791800 @default.
• W2136749710 cites W1998172552 @default.
• W2136749710 cites W1999833688 @default.
• W2136749710 cites W2000406927 @default.
• W2136749710 cites W2015192504 @default.
• W2136749710 cites W2016837466 @default.
• W2136749710 cites W2029902056 @default.
• W2136749710 cites W2032132880 @default.
• W2136749710 cites W2035790329 @default.
• W2136749710 cites W2050724625 @default.
• W2136749710 cites W2050744280 @default.
• W2136749710 cites W2057438016 @default.
• W2136749710 cites W2061897451 @default.
• W2136749710 cites W2075499032 @default.
• W2136749710 cites W2098543768 @default.
• W2136749710 cites W2100138080 @default.
• W2136749710 cites W2101549536 @default.
• W2136749710 cites W2107822667 @default.
• W2136749710 cites W2109020754 @default.
• W2136749710 cites W2109525305 @default.
• W2136749710 cites W2147993424 @default.
• W2136749710 cites W2160097418 @default.
• W2136749710 cites W2162182377 @default.
• W2136749710 cites W2163173921 @default.
• W2136749710 cites W2186559606 @default.
• W2136749710 cites W2194505561 @default.
• W2136749710 cites W2221330666 @default.
• W2136749710 cites W2233373395 @default.
• W2136749710 cites W2276737872 @default.
• W2136749710 cites W4235593722 @default.
• W2136749710 doi "https://doi.org/10.1096/fj.03-0115fje" @default.
• W2136749710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14563685" @default.
• W2136749710 hasPublicationYear "2003" @default.
• W2136749710 type Work @default.
• W2136749710 sameAs 2136749710 @default.
• W2136749710 citedByCount "175" @default.
• W2136749710 countsByYear W21367497102012 @default.
• W2136749710 countsByYear W21367497102013 @default.
• W2136749710 countsByYear W21367497102014 @default.
• W2136749710 countsByYear W21367497102015 @default.
• W2136749710 countsByYear W21367497102016 @default.
• W2136749710 countsByYear W21367497102017 @default.
• W2136749710 countsByYear W21367497102018 @default.
• W2136749710 countsByYear W21367497102019 @default.
• W2136749710 countsByYear W21367497102020 @default.
• W2136749710 countsByYear W21367497102021 @default.
• W2136749710 countsByYear W21367497102022 @default.
• W2136749710 countsByYear W21367497102023 @default.
• W2136749710 crossrefType "journal-article" @default.
• W2136749710 hasAuthorship W2136749710A5015343493 @default.
• W2136749710 hasAuthorship W2136749710A5046597133 @default.
• W2136749710 hasAuthorship W2136749710A5050151730 @default.
• W2136749710 hasAuthorship W2136749710A5052573063 @default.
• W2136749710 hasAuthorship W2136749710A5074715088 @default.
• W2136749710 hasAuthorship W2136749710A5076529079 @default.
• W2136749710 hasConcept C120770815 @default.
• W2136749710 hasConcept C126322002 @default.
• W2136749710 hasConcept C134018914 @default.
• W2136749710 hasConcept C164007495 @default.
• W2136749710 hasConcept C185592680 @default.
• W2136749710 hasConcept C2776992346 @default.
• W2136749710 hasConcept C2777468819 @default.
• W2136749710 hasConcept C2777622882 @default.
• W2136749710 hasConcept C2779610285 @default.
• W2136749710 hasConcept C515207424 @default.
• W2136749710 hasConcept C519581460 @default.
• W2136749710 hasConcept C541997718 @default.
• W2136749710 hasConcept C55493867 @default.
• W2136749710 hasConcept C71924100 @default.
• W2136749710 hasConcept C86803240 @default.
• W2136749710 hasConcept C98274493 @default.
• W2136749710 hasConceptScore W2136749710C120770815 @default.

• next